title: Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitro.
abstract: Oxymorphazone (at doses of 50-200 mg/kg) was found to be a relatively weak antinociceptive drug in intact frog (Rana esculenta) when acetic acid was used as pain stimulus. Frogs remained analgesic for at least 48 hrs following oxymorphazone (200 mg/kg) administration. The ligand increased the latency of wiping reflex in spinal frogs too. These effects were blocked by naloxone. In equilibrium binding studies (3H)oxymorphazone had high affinity to the opioid receptors of frog brain and spinal cord as well (apparent Kd values were 8.9 and 10.6 nM, respectively). Kinetic experiments show that only 25% of the bound (3H)oxymorphazone is readily dissociable. Preincubation of the membranes with labeled oxymorphazone results in a washing resistant inhibition of the opioid binding sites. At least 70% of the (3H)oxymorphazone specific binding is apparently irreversible after reaction at 5 nM ligand concentration, and this can be enhanced by a higher concentration of tritiated ligand.
authors: Institute of Biochemistry, Hungarian Academy of Sciences, Szeged.
authors: S
authors: S
authors: Benyhe
authors: G
authors: G
authors: Hoffmann
authors: E
authors: E
authors: Varga
authors: S
authors: S
authors: Hosztafi
authors: G
authors: G
authors: Toth
authors: A
authors: A
authors: Borsodi
authors: M
authors: M
authors: Wollemann
mesh_terms: D000700:Analgesics; D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004091:Hydromorphone / Q000031:analogs & derivatives*; D007700:Kinetics; D009270:Naloxone / Q000494:pharmacology; D010111:Oxymorphone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology; D011893:Rana esculenta; D011957:Receptors, Opioid / Q000378:metabolism*; D013116:Spinal Cord / Q000378:metabolism
chemical_list: D000700:Analgesics; D011957:Receptors, Opioid; D009270:Naloxone; C034640:oxymorphazone; D010111:Oxymorphone; D004091:Hydromorphone